Loading...
Market
What will be the primary reason cited for any potential regulatory challenge to Orchid's technology by the end of 2024?
2
Resolution / Starting Odds
Ethical concerns • 25%
Privacy issues • 25%
Accuracy of technology • 25%
Market competition • 25%
Official statements from regulatory bodies or legal documents
Story
Orchid Pioneers Embryo Screening with Polygenic Risk Scores, Ushering in Silicon Valley Superbaby Era
Jul 19, 2024, 06:14 PM
Orchid, a startup founded by Noor Siddiqui, is pioneering the use of polygenic risk scores to screen IVF embryos for future health risks. The company promises to sequence over 99% of an embryo's DNA from just five cells, a significant advancement compared to previous methods that sequenced less than 1%. This technology aims to provide prospective parents with greater insights into the health of their future children. High-profile backers of Orchid include crypto evangelists Brian Armstrong, Vitalik Buterin, Balaji Srinivasan, and tech entrepreneur Elon Musk, who has already used the service for his child. The concept of genetically screening embryos has gained traction in Silicon Valley, with some suggesting it could become mainstream, leading to the dawn of the Silicon Valley superbaby.
View original story
Similar markets
No challenge • 25%
From a competitor • 25%
From a regulatory body • 25%
From a consumer group • 25%
High costs • 25%
Technical incompatibility • 25%
Legal/Regulatory issues • 25%
Other • 25%
European Commission • 25%
U.S. Federal Trade Commission • 25%
China's State Administration for Market Regulation • 25%
Other • 25%
Antitrust violations • 25%
Breach of original mission • 25%
Improper investor agreements • 25%
Other legal reasons • 25%
Privacy invasion • 25%
Data misuse • 25%
Security vulnerabilities • 25%
Other • 25%
Addiction concerns • 25%
Data privacy violations • 25%
Misrepresentation of safety • 25%
Other reasons • 25%
National Security • 25%
Economic Impact • 25%
Human Rights • 25%
Other • 25%
Violation of free speech rights • 25%
Overreach of state authority • 25%
Negative impact on business • 25%
Other • 25%
Data privacy • 25%
Ethical use • 25%
Security risks • 25%
Economic impact • 25%
Most regulations upheld • 33%
Most regulations overturned • 33%
Mixed outcomes • 34%
Another FTC action • 25%
Class action lawsuit • 25%
State-level regulatory action • 25%
No significant action • 25%
